Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

This paragraph says it all:

Overpromising and underdelivering is frankly the death knell of any small-cap company, but it’s especially punishing for uplisted companies because they are often unknown and lack institutional sponsorship. When uplisted companies start out their lives on Nasdaq or NYSE by failing to achieve the expectations they’ve set for the market, it’s nearly impossible for them to recover.

ELTP is the king of over promising and underdelivering. I have been saying this for years. If you want to play on a bigger exchange you need to at least attempt to act like it.